Cell Growth & Differentiation, Vol 3, Issue 7 391-399, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid

S Kharbanda, R Datta, E Rubin, T Nakamura, R Hass and D Kufe
Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

The present work has examined the effects of okadaic acid, an inhibitor of type 1 and 2A protein phosphatases, on the regulation of c-jun expression during monocytic differentiation of U-937 leukemia cells. The results demonstrate that okadaic acid treatment is associated with induction of a differentiated monocyte phenotype characterized by: (a) growth arrest; (b) increases in Mac-1 cell surface antigen expression; (c) down-regulation of c-myc transcripts; and (d) induction of tumor necrosis factor gene expression. This induction of monocytic differentiation was associated with transient increases in c-jun mRNA levels, which were maximal at 6 h. Similar effects were obtained for the c-fos gene. Run-on analysis demonstrated detectable levels of c-jun transcription in U-937 cells and that this rate is increased approximately 40-fold following okadaic acid exposure. c-jun mRNA levels were superinduced in cells treated with both okadaic acid and cycloheximide, whereas inhibition of protein synthesis had little, if any, effect on okadaic acid-induced c-jun transcription. The half-life of c-jun mRNA was similar (45-50 min) in both untreated and okadaic acid-induced cells. In contrast, treatment with both okadaic acid and cycloheximide was associated with stabilization (t 1/2 = 90 min) of c-jun transcripts. Taken together, these findings indicate that the induction of c-jun transcription by okadaic acid is controlled primarily by a transcriptional mechanism. Since previous studies have demonstrated that the c-jun gene is autoinduced by Jun/AP-1, we also studied transcription of c-jun promoter (positions -132/+170)-reporter gene constructs with and without a mutated AP-1 element.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Rangatia, R. K. Vangala, N. Treiber, P. Zhang, H. Radomska, D. G. Tenen, W. Hiddemann, and G. Behre Downregulation of c-Jun Expression by Transcription Factor C/EBP{alpha} Is Critical for Granulocytic Lineage Commitment Mol. Cell. Biol., December 15, 2002; 22(24): 8681 - 8694. [Abstract] [Full Text] [PDF]

				K. Yoshida and D. Kufe Negative Regulation of the SHPTP1 Protein Tyrosine Phosphatase by Protein Kinase C delta in Response to DNA Damage Mol. Pharmacol., December 1, 2001; 60(6): 1431 - 1438. [Abstract] [Full Text] [PDF]

				L. M. L. Tuyt, W. H. A. Dokter, K. Birkenkamp, S. B. Koopmans, C. Lummen, W. Kruijer, and E. Vellenga Extracellular-Regulated Kinase 1/2, Jun N-Terminal Kinase, and c-Jun Are Involved in NF-{kappa}B-Dependent IL-6 Expression in Human Monocytes J. Immunol., April 15, 1999; 162(8): 4893 - 4902. [Abstract] [Full Text] [PDF]

				M. Kaneki, S. Kharbanda, P. Pandey, K. Yoshida, M. Takekawa, J.-R. Liou, R. Stone, and D. Kufe Functional Role for Protein Kinase Cbeta as a Regulator of Stress-Activated Protein Kinase Activation and Monocytic Differentiation of Myeloid Leukemia Cells Mol. Cell. Biol., January 1, 1999; 19(1): 461 - 470. [Abstract] [Full Text] [PDF]

				M. Silvy, P.-M. Martin, N. Chajry, and Y. Berthois Differential Dose-Dependent Effects of Epidermal Growth Factor on Gene Expression in A431 Cells: Evidence for a Signal Transduction Pathway That Can Bypass Raf-1 Activation Endocrinology, May 1, 1998; 139(5): 2382 - 2391. [Abstract] [Full Text] [PDF]